Re: ZEN-3694 mCRPC Trial Status
in response to
by
posted on
Oct 24, 2017 12:04PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Which beg the question whether or not Pfizer or another pharma is knocking on the door and wants in now or will they wait it out til a phase 3 trial is completed.....